20/11/23 -"Following our reassessment of the badwill after the CS acquisition, we project lower UBS equity, thus a higher Roe and mechanically a higher intrinsic valuation."
Pages
52
Language
English
Published on
20/11/23
You may also be interested by these reports :
23/09/26
Following the CMD, we have updated our projections to reflect both the new inputs provided by the management as well as the slightly downgraded macro ...
21/09/26
SocGen’s 2026 CMD “enhances” its turnaround: 3% revenue CAGR, absolute cost cut (€16.3bn cost target in 2029), C/I ratio below 55%, and 13-14% ROTE ...
16/09/26
Reading European equities earnings dynamic, i.e. revisions, remains a brain torturing exercise for anyone wondering where the 2026 earnings growth at ...
08/09/26
We have decreased our TP on the back of our negative 2027 EPS revision (see below), as well as on the back of our trimmed dividend and buyback ...